Delivery Order SPE2DB24D3013-SPE2DB25FFMJU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,877.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child delivery order issued under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $22,131.79 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, competitive award carries an ultimate completion date of August 21, 2025, and represents a child delivery order under AmerisourceBergen's broader contract vehicle with DLA. The contract is not set-aside and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count supply) under a firm fixed-price contract valued at $11,743.92. The award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $13,924.72. The award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $15,640.97. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $15,602.23 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $15,289.31. The award, issued on June 2, 2025, with completion targeted for June 3, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. This delivery order was competitively awarded with no set-aside designation, and performance is based at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $14,354.81 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMJUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $11,371.30, with a completion date of June 11, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order fulfills federal pharmaceutical supply requirements as part of DLA's comprehensive medical supply chain operations, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC vehicle to supply a diverse portfolio of medications across multiple therapeutic domains to support military healthcare programs worldwide. The Jardiance order exemplifies the company's role in providing critical diabetes management medications to federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 6/10/25 |